EP1311239A4 - ORAL ADMINISTRATION OF PEPTIDES - Google Patents

ORAL ADMINISTRATION OF PEPTIDES

Info

Publication number: EP1311239A4
Authority: EP; European Patent Office
Prior art keywords: peptides; oral administration; oral; administration
Prior art date: 2000-08-11
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP00952034A

Other languages

German (de)

French (fr)

Other versions

EP1311239A1 (en

Inventor

Hack-Joo Kim

Heung-Man An

Min-Jong Cha

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Hyundai Pharm Co Ltd

Original Assignee

Hyundai Pharmaceutical Ind Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2000-08-11

Filing date

2000-08-11

Publication date

2005-06-22

2000-08-11 Application filed by Hyundai Pharmaceutical Ind Co Ltd filed Critical Hyundai Pharmaceutical Ind Co Ltd

2003-05-21 Publication of EP1311239A1 publication Critical patent/EP1311239A1/en

2005-06-22 Publication of EP1311239A4 publication Critical patent/EP1311239A4/en

Status Withdrawn legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
- A61K9/1277—Preparation processes; Proliposomes

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Chemical Kinetics & Catalysis (AREA)
Diabetes (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Endocrinology (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Biophysics (AREA)
Molecular Biology (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Hematology (AREA)
Obesity (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

EP00952034A 2000-08-11 2000-08-11 ORAL ADMINISTRATION OF PEPTIDES Withdrawn EP1311239A4 (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
PCT/KR2000/000892 WO2002013782A1 (en)	2000-08-11	2000-08-11	Oral delivery of peptide

Publications (2)

Publication Number	Publication Date
EP1311239A1 EP1311239A1 (en)	2003-05-21
EP1311239A4 true EP1311239A4 (en)	2005-06-22

Family

ID=19198254

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP00952034A Withdrawn EP1311239A4 (en)	2000-08-11	2000-08-11	ORAL ADMINISTRATION OF PEPTIDES

Country Status (6)

Country	Link
EP (1)	EP1311239A4 (en)
JP (1)	JP2004506003A (en)
CN (1)	CN1479609A (en)
AU (1)	AU2000264796A1 (en)
CA (1)	CA2420032A1 (en)
WO (1)	WO2002013782A1 (en)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6761901B1 (en)	2000-05-02	2004-07-13	Enzrel Inc.	Liposome drug delivery
US8658202B2 (en)	2001-04-25	2014-02-25	Western University Of Health Sciences	Coated drug delivery formulations
US6759058B1 (en) *	2001-04-25	2004-07-06	Western Center For Drug Development College Of Pharmacy Western University Of Health Sciences	Enteric-coated proliposomal formulations for poorly water soluble drugs
JP2005523249A (en)	2002-01-09	2005-08-04	エンズレルインコーポレイテッド	Liposomal drug delivery of polycyclic aromatic antioxidants or anti-inflammatory compounds
CN100371018C (en) *	2003-06-12	2008-02-27	刘青松	Calcitonin composition
JP4669665B2 (en) *	2004-04-12	2011-04-13	正彦阿部	Polycation-modified liposome having no cytotoxicity and method for producing the same
WO2006062506A1 (en) *	2004-12-03	2006-06-15	Enzrel, Inc.	Chitosan-coated liposome drug delivery of antioxidant or anti-inflammatory compounds
JP2008179563A (en) *	2007-01-24	2008-08-07	Cosmo Shokuhin Kk	Functional material and functional food comprising useful phospholipid composition
WO2009149537A1 (en) *	2008-06-12	2009-12-17	Christine Allen	Injectable polymer-lipid blend
ES2638815T5 (en)	2009-06-18	2025-06-26	Acerus Pharmaceuticals Usa Llc	Safe desmopressin administration
CN103127003B (en) *	2013-03-19	2014-05-07	广东彼迪药业有限公司	Omeprazole enteric micropelets and capsule as well as preparation method thereof
CN105902400B (en) *	2016-06-17	2019-10-11	四川百奥可生物科技有限责任公司	A kind of particle and its preparation method and application of wrapping biological enzyme
CN107952063A (en) *	2017-12-27	2018-04-24	北京四环生物制药有限公司	Calcitonin piece and preparation method thereof
CN114081963B (en) *	2021-11-16	2023-09-26	上海理工大学	Nanometer carrier for improving bioavailability of active peptide and preparation and application thereof
CN114010801B (en) *	2021-11-16	2023-09-26	上海理工大学	L-ascorbyl palmitate modified small molecule peptide liposome and preparation and application thereof
CN116407621A (en) *	2021-12-30	2023-07-11	武汉虹辰远荣生物制品有限公司	A kind of natto product that can help prevent Alzheimer's disease

Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4615885A (en) *	1983-11-01	1986-10-07	Terumo Kabushiki Kaisha	Pharmaceutical composition containing urokinase
EP0855179A2 (en) *	1997-01-16	1998-07-29	Lipotec, S.A.	Pharmaceutical preparation comprising coated capsules or tablets containing a liposome powder encapsulating a drug

2000
- 2000-08-11 WO PCT/KR2000/000892 patent/WO2002013782A1/en not_active Ceased
- 2000-08-11 CA CA002420032A patent/CA2420032A1/en not_active Abandoned
- 2000-08-11 EP EP00952034A patent/EP1311239A4/en not_active Withdrawn
- 2000-08-11 AU AU2000264796A patent/AU2000264796A1/en not_active Abandoned
- 2000-08-11 CN CNA008198144A patent/CN1479609A/en active Pending
- 2000-08-11 JP JP2002518929A patent/JP2004506003A/en active Pending

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4615885A (en) *	1983-11-01	1986-10-07	Terumo Kabushiki Kaisha	Pharmaceutical composition containing urokinase
EP0855179A2 (en) *	1997-01-16	1998-07-29	Lipotec, S.A.	Pharmaceutical preparation comprising coated capsules or tablets containing a liposome powder encapsulating a drug

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO0213782A1 *

Also Published As

Publication number	Publication date
JP2004506003A (en)	2004-02-26
CA2420032A1 (en)	2002-02-21
WO2002013782A1 (en)	2002-02-21
CN1479609A (en)	2004-03-03
AU2000264796A1 (en)	2002-02-25
EP1311239A1 (en)	2003-05-21

Legal Events

Date	Code	Title	Description
2003-04-04	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2003-05-21	17P	Request for examination filed	Effective date: 20030211
2003-05-21	AK	Designated contracting states	Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
2003-05-21	AX	Request for extension of the european patent	Extension state: AL LT LV MK RO SI
2004-05-12	RBV	Designated contracting states (corrected)	Designated state(s): BE DE ES FR GB IT
2005-06-22	A4	Supplementary search report drawn up and despatched	Effective date: 20050506
2005-06-22	RIC1	Information provided on ipc code assigned before grant	Ipc: 7A 61K 9/28 B Ipc: 7A 61K 9/20 B Ipc: 7A 61K 9/127 A
2006-07-21	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2006-08-23	18D	Application deemed to be withdrawn	Effective date: 20060301

Publication	Publication Date	Title
NO20071303L (en)	2001-07-27	Pharmaceutical preparations
ITTO20010008A0 (en)	2001-01-10	PHARMACEUTICAL FORMULATION
EE200000395A (en)	2002-02-15	Oral pharmaceutical pulsatile dosage form
DK1210113T3 (en)	2006-07-03	Combined vaccine preparations
ATE296619T1 (en)	2005-06-15	SOLID ORAL DOSAGE FORM OF SIMETHICON
NO20033556D0 (en)	2003-08-11	Pharmaceutical preparations
CY2014003I1 (en)	2015-12-09	PHARMACEUTICAL FORMS OF Echinocandin CONTAINING MICCULE-FORMING SURFACTANTS
FIU20000164U0 (en)	2000-04-11	New pharmaceutical formulation
DE60024988D1 (en)	2006-01-26	PREPARATION OF THERAPEUTIC MICROSCIENTS
IS5245A (en)	1999-11-11	Pharmaceutical preparation of omeprazole
DE60038698D1 (en)	2008-06-05	HYDROGEL-CONTROLLED DOSAGE FORM
EE200000383A (en)	2001-12-17	Oral pharmaceutical extended release dosage form
FI991485A0 (en)	1999-06-30	New pharmaceutical composition
EP1383518A4 (en)	2005-11-09	ORAL ADMINISTRATION OF MACROMOLECULES
NO20030627L (en)	2003-04-08	Hydrogel-driven drug dosage form
CY2013011I1 (en)	2015-08-05	METHOD OF ADMINISTRATION OF DIPHOSPHONICS
EE200200038A (en)	2003-04-15	Preserved pharmaceutical preparations
EP1311239A4 (en)	2005-06-22	ORAL ADMINISTRATION OF PEPTIDES
ATE252915T1 (en)	2003-11-15	SUSTAINED RELEASE PEPTIDE FORMULATION
EE05020B1 (en)	2008-06-16	The pharmaceutical composition of G1buride
DE60126089D1 (en)	2007-03-08	ADMINISTRATION SYSTEM
DZ3219A1 (en)	2001-02-22	VACCINE
NO20015670L (en)	2001-11-20	Improved pharmaceutical formulations
NO20025114D0 (en)	2002-10-24	Thrombopoietin receptor modulating peptide
NO20022606L (en)	2002-07-11	Pharmaceutical combinations